Orum Therapeutics Inc (475830) Stock Price & News

475830:KOSDAQ

Orum Therapeutics Inc

₩15,000.00

+1.15%

(+170.00) 1D

Nov 13, 3:30:22 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 475830...

Open

₩14,970

High

₩16,380

Low

₩14,760

Mkt. cap

326.29B

Avg. vol.

196.44K

Volume

188.28K

52-wk high

₩146,600

52-wk low

₩13,650

EPS

-₩2,756

Shares outstanding

21.75M

No. of employees

Open

₩14,970

High

₩16,380

Low

₩14,760

Mkt. cap

326.29B

Avg. vol.

196.44K

Volume

188.28K

52-wk high

₩146,600

52-wk low

₩13,650

EPS

-₩2,756

Shares outstanding

21.75M

No. of employees

Related stocks

LigaChem Biosciences Inc

News stories

From web sources and news partners

Yahoo Finance

33 minutes ago

Stock market today: Dow, S&P 500, Nasdaq futures waver as Nvidia tumult deepens

Reuters

27 minutes ago

Nasdaq futures dip as Nvidia tumult keeps investors on edge

Bloomberg.com

1 hour ago

Goldman Sees S&P 500 Rising 14% on Cheap Hyperscaler Valuations

CNBC

31 minutes ago

Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump

About Orum Therapeutics Inc

CEO-

Employees24

Founded2016

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websiteorumrx.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	15.89M	558.17K	-	24.11M
Cost of goods sold	-	-	170.00K	150.00K
Cost of revenue	-	-	170.00K	150.00K
Research and development expenses	9.89B	13.98B	13.80B	10.77B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.39B	3.22B	3.26B	3.69B
Operating expense	13.95B	18.26B	18.08B	15.38B
Total operating expenses	13.95B	18.26B	18.08B	15.38B
Operating income	-13.94B	-18.25B	-18.08B	-15.35B
Other non operating income	-1.08M	34.77M	48.71M	86.22B
EBT including unusual items	-13.62B	-18.16B	-15.28B	63.38B
EBT excluding unusual items	-14.48B	-18.73B	-17.18B	69.64B
Income tax expense	-	-2.18B	-	-
Effective tax rate	-	12.02%	-	-
Other operating expenses	35.19M	87.88M	188.21M	77.90M
Net income	-13.62B	-15.97B	-15.28B	63.38B
Net profit margin	-85,717.86%	-2,862,010.66%	-	262,947.93%
Earnings per share	-	-	-	-
Interest and investment income	350.80M	226.55M	648.35M	1.09B
Interest expense	-461.04M	-478.02M	-469.06M	-481.67M
Net interest expenses	-110.24M	-251.46M	179.30M	606.25M
Depreciation and amortization charges	646.77M	974.08M	831.64M	833.15M
EBITDA	-13.29B	-17.28B	-17.24B	-14.52B
Gain or loss from assets sale	-	70.25M	-	-9.08M

Ask anything